Phase III EURO-SKI: Cessation of TKI Therapy Safe, Feasible for Pts Who Achieve Deep Molecular Response

Slideset - Factors associated with MRFS after TKI cessation included longer durations of imatinib therapy, MR4, and pretreatment IFN.

Source: Clinical Care Options Leukemia - December 9, 2016 Category: Hematology Source Type: research